← Open Payments lookup

ABRA BLACK: Open Payments

NPI 1174001291 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,094 in 66 payments from 14 companies in 2025. Trend: 2023 $667 · 2024 $831 · 2025 $1,094

Food & beverage: $1,094
CompanyPaymentsAmount
Novo Nordisk Inc15$177
AstraZeneca Pharmaceuticals LP7$167
ABBVIE INC.11$151
Lilly USA, LLC9$138
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$102
Vanda Pharmaceuticals Inc.4$77
Axsome Therapeutics, Inc.3$59
Otsuka America Pharmaceutical, Inc.2$45
PFIZER INC.2$41
Boehringer Ingelheim Pharmaceuticals, Inc.2$36

Products named: VRAYLAR, Ozempic, MOUNJARO, CAPLYTA, FARXIGA, FANAPT, BREZTRI, Auvelity.

Industry payments across IN — which companies pay providers there.